Pablo
Pelegrin Vivancos
Catedraticos de Universidad
Hospital Ramón y Cajal
Madrid, EspañaPublikationen in Zusammenarbeit mit Forschern von Hospital Ramón y Cajal (2)
2020
-
NLRP3 inflammasome as prognostic factor and therapeutic target in primary progressive multiple sclerosis patients
Brain : a journal of neurology, Vol. 143, Núm. 5, pp. 1414-1430
2012
-
Cell Volume Regulation Modulates NLRP3 Inflammasome Activation
Immunity, Vol. 37, Núm. 3, pp. 487-500